Navigation Links
Schizophrenia Patients Who Take Antipsychotics Live Longer, Study Says
Date:11/14/2012

WEDNESDAY, Nov. 14 (HealthDay News) -- People with schizophrenia are likely to live longer if they take their antipsychotic drugs on schedule, avoid extremely high doses and have regular visits with a mental-health professional, according to a new study.

It's long been known that adhering to a drug regimen reduces the number of the delusions and hallucinations experienced by schizophrenia patients, but there have been concerns that known physical side effects of the medications -- such as diabetes and heart disease -- might increase the risk of death.

In this study, researchers analyzed data collected from 1994 to 2004 on more than 2,100 adult schizophrenia patients in Maryland. The most common cause of death was cardiovascular disease, which was responsible for 28 percent of patient deaths. Unintended harm, in which researchers included suicide, caused 8 percent of patient deaths during the study period.

Patients with a 90 percent or better compliance with their antipsychotic medication regimen had a 25 percent lower risk of death than those with a compliance of less than 10 percent.

The researchers also found that each additional visit per year to a mental-health professional was associated with a 5 percent reduction in overall death risk.

Although sticking with an antipsychotic drug regimen reduced the risk of death, the researchers found that patients who took high doses of first-generation antipsychotics daily had an 88 percent increased risk of death.

First-generation antipsychotics have been linked with heart disease risks, and among the patients who died in the study while taking larger doses, 53 percent died of cardiovascular disease.

"These drugs work very well, but there is clearly a point of diminishing returns. You rarely need to be on extremely high doses," study leader Bernadette Cullen, assistant professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine, in Baltimore, said in a university news release.

The study was published online Oct. 30 in the journal Schizophrenia Bulletin.

"We know that antipsychotic medications reduce symptoms, and our study shows that staying on reasonable, recommended doses is associated with longer life," Cullen said. "The same is true for going to see a psychiatrist or therapist."

Cullen noted that regular visits to a mental-health professional are one way to monitor and encourage drug-use compliance, but also in and of themselves increase survival among schizophrenia patients.

"If people are taking their medications, they usually have fewer symptoms and are able to be more organized in other areas of their lives," said Cullen, who also is director of community psychiatry at the Johns Hopkins Hospital.

"We believe they are then more likely to make appointments with their primary care doctors, to stay on top of other illnesses they may have and to regularly take diabetes, blood pressure or cholesterol medication that they may require to stay healthy," she said. "We also believe that they are more likely to be socially engaged and have a healthier lifestyle."

Although the researchers found an association between strict antipsychotic drug regimens and longer life among people with schizophrenia, they did not prove a cause-and-effect relationship.

More information

The U.S. National Institute of Mental Health has more about schizophrenia.

-- Robert Preidt

SOURCE: Johns Hopkins Medicine, news release, November 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Study: Use of antipsychotic drugs improves life expectancy for individuals with schizophrenia
2. Older Dads May Raise Risk for Autism, Schizophrenia in Kids
3. Schizophrenia in Movies: Dont Believe Everything You See
4. Using biomarkers to identify and treat schizophrenia
5. Mount Sinai finds common factors in autism spectrum disorders, schizophrenia, and bipolar disorder
6. Family History of Schizophrenia, Bipolar Disorder May Up Kids Risk for Autism
7. Feinstein Institute to Receive Grant from Centers for Medicare & Medicaid Services to Improve Schizophrenia Treatment
8. Feinstein Institute to receive grant to improve schizophrenia treatment
9. Fewer suicides after antidepressive treatment for schizophrenia
10. Antipsychotics Do Help Many With Schizophrenia, Study Finds
11. Genes Associated With Autism Also Related to Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Schizophrenia Patients Who Take Antipsychotics Live Longer, Study Says
(Date:6/27/2016)... CA (PRWEB) , ... June 27, 2016 , ... ... College District , the only authorized OSHA Training Institute Education Center headquartered in ... by protecting their workers from extreme heat at their worksites. Employers with ...
(Date:6/27/2016)... ... 2016 , ... "FCPX editors can now reveal their media with growing colorful ... Christina Austin - CEO of Pixel Film Studios. , ProSlice Color brings the ... can now reveal the media of their split screens with growing colorful panels. , ...
(Date:6/27/2016)... , ... June 27, 2016 , ... ... mental health professionals, announced today its affiliation with Tennessee Counseling Association. ... to the network of the Tennessee Counseling Association, adding exclusive benefits and promotional ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... payment industry today announced its strategic partnership with Connance, a healthcare industry ... The two companies’ proven, proprietary technology combine to provide health systems, hospitals ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... cutting edge technology to revolutionize the emergency ambulance transport experience for the millions ... aware of how Uber has disrupted the taxi industry through the use of ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 26, 2016 One of Australia,s ... formation of a new biotechnology company, Noxopharm Limited [ABN 50 608 ... IPO and to list on the ASX. Noxopharm is ... to enter a Phase 1 clinical study later this year. ... one of the biggest problems facing cancer patients - the ability ...
(Date:6/26/2016)... DUBLIN , June 27, 2016 Jazz ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... proposed acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... 11:59 p.m. (Eastern Daylight Time). As previously ... entered into a definitive merger agreement under which Jazz ...
(Date:6/26/2016)... 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) ... measures required to build a strong and stable market ... listed on the OTC Markets-pink current trading platform. ... "We are seeing an anomaly in market trading activities ... by the Company, but shareholders and market players as ...
Breaking Medicine Technology: